Teixobactin: A Resistance-Evading Antibiotic for Treating Anthrax
William S. Lawrence(The University of Texas Medical Branch at Galveston), Dallas E. Hughes(NovoBiotic Pharmaceuticals), Markus Weingarth(University of Applied Sciences Utrecht), Aaron J. Peoples(NovoBiotic Pharmaceuticals), Jennifer E. Peel(The University of Texas Medical Branch at Galveston), Henry S. Heine(University of Florida), Rhythm Shukla(Utrecht University), Anthony Nitti(NovoBiotic Pharmaceuticals), Losee L. Ling(NovoBiotic Pharmaceuticals), Martha E. Hensel, Kim Lewis(Northeastern University), Rosan de Winter(Utrecht University), Elbert B. Whorton(The University of Texas Medical Branch at Galveston), Harold D. MacGillavry(Amsterdam Neuroscience)
Cited by 3
Related Papers
Definitions and guidelines for research on antibiotic persistence
|Nature Reviews Microbiology|2019|1.3k
Tackling antibiotic resistance
|Nature Reviews Microbiology|2011|1.1k
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
|PLoS Biology|2010|772